NYSE:CVSHealthcare
A Look At CVS Health (CVS) Valuation After Guidance Reaffirmation And Medicare Advantage Update
CVS Health (CVS) is back in focus after reaffirming its earnings guidance and outlining plans to improve Aetna margins, as investors digest a higher than expected 2027 Medicare Advantage payment update and easing regulatory questions around insulin pricing.
See our latest analysis for CVS Health.
The reaffirmed earnings outlook and support for Aetna margins have arrived alongside a 30 day share price return of 11.7% and a 1 year total shareholder return of 26.1%. This suggests recent momentum...